TaskUs에 대한 매도 수량은 투자자에게 TaskUs의 주식 하락에 베팅하는 정도를 알려줍니다. 매도 수량 데이터는 2주마다 업데이트됩니다.

TaskUs (NASDAQ:TASK) 주식, 공매도 수량 보고

TASKUS INC-A

TaskUs

TaskUs Inc is a provider of outsourced digital services and next-generation customer experience to the world's most innovative companies, helping its clients represent, protect and grow their brands. It serves clients in the fastest-growing sectors, including social media, e-commerce, gaming, streaming media, food delivery and ridesharing, HiTech, FinTech and HealthTech.

TaskUs Inc

JMP Securities analyst Andrew Boone maintains Grindr (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GRND#NYSE">GRND</a>) with a Market Outperform and raises the price target from $24 to $27.

News

Price Target

Analyst Ratings

GRND

JMP Securities Maintains Market Outperform on Grindr, Raises Price Target to $27

Regencell Bioscience (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RGC#NASDAQ">RGC</a>) reported quarterly losses of $(0.36) per share. This is a 14.29 percent increase over losses of $(0.42) per share from the same period last year.

Earnings

Regencell Bioscience H1 EPS $(0.36) Up From $(0.42) YoY

High-Trend International Group (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HTCO#NASDAQ">HTCO</a>), a Nasdaq-listed global shipping and logistics company, proudly acknowledges the recent correspondence from President Donald J. Trump in response to a letter submitted by Mr. Brian B. Su, the Company's Independent Director and Chairman of the Compensation Committee. In his letter dated June 18, 2025, President Trump expressed appreciation for Mr. Su's views on restoring American strength on the world stage and reaffirmed his administration's commitment to revitalizing American leadership, defense readiness, and strategic dominance in global affairs.

HTCO

High-Trend International Acknowledges President Trump Letter To Board Chairman On Company Affairs

Contracts

BZAI

Blaize Holdings Announces Its AI Platform Will Be Deployed Across Intelligence Surveillance Endpoints; Total Value Of Contracted Purchase Order ~$56M

<h3>Gainers</h3>
<table>
<thead>
<tr>
<th>Symbol</th>
<th>Name</th>
<th align="right">Price</th>
<th align="right">Change ($)</th>
<th align="right">Change (%)</th>
<th>Volume</th>
</tr>
</thead>
<tbody>
<tr>
<td>(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XLK#NYSE">XLK</a>)</td>
<td>SPDR Select Sector Fund - Technology</td>
<td align="right">252.8400</td>
<td align="right">2.070</td>
<td align="right">0.82</td>
<td>75.3K</td>
</tr>
<tr>
<td>(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XLC#NYSE">XLC</a>)</td>
<td>The Communication Services Select Sector SPDR Fund</td>
<td align="right">108.5600</td>
<td align="right">0.880</td>
<td align="right">0.81</td>
<td>8.9K</td>
</tr>
<tr>
<td>(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XLF#NYSE">XLF</a>)</td>
<td>SPDR Select Sector Fund - Financial</td>
<td align="right">52.1850</td>
<td align="right">0.245</td>
<td align="right">0.47</td>
<td>330.5K</td>
</tr>
<tr>
<td>(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XLRE#NYSE">XLRE</a>)</td>
<td>Real Estate Select Sector SPDR Fund (The)</td>
<td align="right">41.2400</td>
<td align="right">0.120</td>
<td align="right">0.29</td>
<td>3.7K</td>
</tr>
<tr>
<td>(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XLB#NYSE">XLB</a>)</td>
<td>Materials Select Sector SPDR</td>
<td align="right">88.0600</td>
<td align="right">0.170</td>
<td align="right">0.19</td>
<td>421</td>
</tr>
<tr>
<td>(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XLV#NYSE">XLV</a>)</td>
<td>SPDR Select Sector Fund - Health Care</td>
<td align="right">134.0100</td>
<td align="right">0.080</td>
<td align="right">0.05</td>
<td>8.1K</td>
</tr>
<tr>
<td>(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XLI#NYSE">XLI</a>)</td>
<td>SPDR Select Sector Fund - Industrial</td>
<td align="right">146.8601</td>
<td align="right">0.070</td>
<td align="right">0.04</td>
<td>5.2K</td>
</tr>
</tbody>
</table>
<h3>Losers</h3>
<table>
<thead>
<tr>
<th>Symbol</th>
<th>Name</th>
<th align="right">Price</th>
<th align="right">Change ($)</th>
<th align="right">Change (%)</th>
<th>Volume</th>
</tr>
</thead>
<tbody>
<tr>
<td>(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XLU#NYSE">XLU</a>)</td>
<td>SPDR Select Sector Fund - Utilities</td>
<td align="right">80.80</td>
<td align="right">-0.53</td>
<td align="right">-0.66</td>
<td>67.4K</td>
</tr>
<tr>
<td>(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XLP#NYSE">XLP</a>)</td>
<td>SPDR Select Sector Fund - Consumer Staples</td>
<td align="right">80.46</td>
<td align="right">-0.09</td>
<td align="right">-0.12</td>
<td>1.6K</td>
</tr>
<tr>
<td>(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XLE#NYSE">XLE</a>)</td>
<td>SPDR Select Sector Fund - Energy Select Sector</td>
<td align="right">85.22</td>
<td align="right">-0.08</td>
<td align="right">-0.10</td>
<td>31.3K</td>
</tr>
</tbody>
</table>
<a href="https://pro.benzinga.com/?utm_source=insights">Pulled from Benzinga Pro data</a> this sector movers alert provides traders with a compiled way to read macro-level market trends. Investors garner a particular interest in sector movers to better determine sectors that are over- or under-performing to make better investing decisions on exchange-traded funds (ETFs) or individual tickers in those sectors. 
For more information on sector movers, <a href="https://www.benzinga.com/movers">click here</a>.

Sector ETFs

Pre-Market Outlook

Movers

ETFs

XLRE

Leading And Lagging Sectors For June 30, 2025

Thomas (Tom) Lee, the Founder of Fundstrat and CIO of Fundstrat Capital, will become Chairman of the Board of Directors effective today.
The transaction was led by MOZAYYX with participation from Founders Fund, Pantera, FalconX, Republic Digital, Kraken, Galaxy Digital, DCG, Diametric Capital, Occam Crest Management, and Thomas Lee.
Upon the closing of the Private Placement, BitMine will advance its treasury strategy on Ethereum.
BitMine Immersion continues to enhance its asset-light and mining business by increasing its existing treasury holdings by over 16x.
LAS VEGAS, June 30, 2025 /PRNewswire/ -- (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BMNR#NYSE">BMNR</a>) ("BitMine" or the "Company") today announced the pricing and signing of a private placement for the purchase and sale of 55,555,556 shares of common stock (or common stock equivalents in lieu thereof) at a price of $4.50 per share for expected aggregate gross proceeds of approximately $250 million before deducting placement agent fees and other offering expenses (funded in a combination of cash and cryptocurrencies) to implement an Ethereum treasury strategy.
The transaction was led by MOZAYYX with participation from a high quality group of investors including Founders Fund, Pantera, FalconX, Republic Digital, Kraken, Galaxy Digital, DCG, Diametric Capital, Occam Crest Management, and Thomas Lee.
The closing of the offering is expected to occur on or about July 3, 2025, subject to the satisfaction of customary closing conditions, including without limitation, the authorization of the Supplemental Listing Application by the NYSE American. The Company intends to use the net proceeds of the offering to acquire the native cryptocurrency of Ethereum blockchain commonly referred to as "ETH" and contribute the ETH to the Company's treasury operations. ETH will serve as the Company's primary treasury reserve asset.

Coverage of Bitcoin, Etherum, Ripple and all the latest digital currencies.

Cryptocurrency

Offerings

Management

Markets

$ETH

BMNR

BitMine Announces $250M Private Placement Of 55.56M Shares Of Common Stock At $4.50/Share To Launch Ethereum Treasury Strategy; Tom Lee Named Chairman

JMP Securities analyst Jordan Bender maintains Genius Sports (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GENI#NYSE">GENI</a>) with a Market Outperform and raises the price target from $12 to $13.

GENI

JMP Securities Maintains Market Outperform on Genius Sports, Raises Price Target to $13

Acuren Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TIC#NYSE">TIC</a>) (the "Company" or "Acuren"), a leading provider of critical asset integrity services, today announced that its registration statement on Form S-4 (the "Registration Statement") filed with Securities and Exchange Commission (the "SEC") in connection with the proposed merger between the Company and NV5 Global, Inc. (("NV5", NASDAQ:<a href="https://www.benzinga.com/stock/NVEE#NASDAQ">NVEE</a>), was declared effective by the SEC on June 27, 2025. Notice of Acuren's meeting of stockholders to be held in connection with the proposed merger and a definitive joint proxy statement/prospectus is expected to be mailed on or about July 1, 2025, to stockholders of record of the Company as of June 30, 2025. BEFORE MAKING ANY VOTING DECISION, THE COMPANY'S STOCKHOLDERS ARE URGED TO READ ALL RELEVANT DOCUMENTS FILED WITH THE SEC, INCLUDING, WHEN AVAILABLE, THE JOINT PROXY STATEMENT/PROSPECTUS, BECAUSE THEY WILL CONTAIN IMPORTANT INFORMATION ABOUT THE PROPOSED MERGER.&nbsp;

NVEE

Acuren Announces SEC Approval Of Registration Statement For Proposed Merger With NV5 Global

Future Fintech Group Inc. (NASDAQ:&nbsp;<a href="https://www.ftft.com/en/">FTFT</a>), (hereinafter referred to as "Future FinTech", "FTFT" or the "Company"),&nbsp;a comprehensive financial and digital technology service provider, today announced certain changes to its management and Board of Directors.
On June 20, 2025, Mr. Ming Yi resigned from his position as the Chief Financial Officer of the Company, Mr. Fuyou Li resigned from his position as the Chairman of the Board and as a member of the Board's audit and compensation committees, and Ms. Ying Li resigned from her positions as a director of the Board and the Vice President of the Company. The resignations of Mr. Ming Yi, Mr. Fuyou Li and Ms. Ying Li from these positions were not a result of any disagreement with the Company on any matter related to the operations, policies, or practices of the Company. To fill these vacancies, on June 26, 2025, the Company's Board of Directors appointed Ms. Ting (Alina) Ouyang as a director of the Board and the Chief Financial Officer of the Company, and Mr. David Xu as the Chairman of the Board and as a member of the Board's audit and compensation committees of the Company.

FTFT

Future Fintech Appoints Ting Ouyang As CFO And David Xu As Chairman Of The Board

KYTX

Kyverna Therapeutics Appoints Marc Grasso, M.D. As CFO, Effective Today

NV5, a provider of technology, certification, and consulting solutions, announced today that it has been awarded over $20 million in engineering design and construction management contracts by the New York City Department of Parks and Recreation to support parks and recreation facility improvements.&nbsp; These awards continue NV5's 20-year relationship designing and overseeing the construction of New York City's more than 1,700 parks and recreational spaces.

NV5 Secures Over $20M In NYC Parks Contracts For Design And Construction Management

JMP Securities analyst Roy Buchanan maintains Cidara Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CDTX#NASDAQ">CDTX</a>) with a Market Outperform and maintains $59 price target.

CDTX

JMP Securities Maintains Market Outperform on Cidara Therapeutics, Maintains $59 Price Target

Biotech

General

AMGN

Amgen Announces Phase 3 FORTITUDE-101 Trial Of Bemarituzumab Plus Chemotherapy  Met Its Primary Endpoint

With upgraded authorization, soon federal agencies with security requirements at every level will be able to use&nbsp;MongoDB to deploy, run, and scale modern applications in the cloud
NEW YORK, June 30, 2025 /PRNewswire/ -- MongoDB, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MDB#NASDAQ">MDB</a>) today announced its commitment to pursuing Federal Risk and Authorization Management Program (FedRAMP) High and Impact Level 5 (IL5) authorizations for MongoDB Atlas for Government workloads, which will expand its eligibility to manage unclassified, yet highly sensitive, U.S. public sector data. With FedRAMP High authorization, even the most critical government agencies looking to adopt cloud and AI technologies—and to modernize aging, inefficient legacy databases—can rely on MongoDB Atlas for Government for secure, fully managed workloads.

MongoDB Announces Commitment To Pursuing FedRAMP High And Impact Level 5 Authorizations For MongoDB Atlas For Government Workloads

JMP Securities analyst Mitch Germain reiterates Agree Realty (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ADC#NYSE">ADC</a>) from Market Perform to Market Perform.

Reiteration

JMP Securities Reiterates Market Perform on Agree Realtyto Market Perform

APDN

Applied DNA Conducts 27% Workforce Reduction And Ceases Operations At Applied DNA Clinical Lab; will focus Exclusively On LineaRx Business

The SEISMiC C Study is the third study in the istaroxime cardiogenic shock development program - SEISMiC C is studying more severely ill SCAI Stage C cardiogenic shock patients
Windtree has previously reported two positive early cardiogenic shock Phase 2 studies in SCAI Stage B patients
The SEISMiC C interim analysis will provide a preliminary assessment of istaroxime safety in treating more severe cardiogenic shock patients who may be receiving standard of care with inotropes and vasopressors
SCAI Stage C is a sicker patient population than early cardiogenic shock and has high mortality despite currently used drug treatments
WARRINGTON, Pa., June 30, 2025 (GLOBE NEWSWIRE) -- Windtree Therapeutics, Inc. ("Windtree" or the "Company") (NasdaqCM: WINT), a diversified company focused on revenue generation in multiple growing industries is pleased to announce that the Company has reached the planned enrollment of 20 patients for the interim analysis in its istaroxime Phase 2 SEISMiC C study in SCAI Stage C cardiogenic shock patients.

WINT

Windtree Therapeutics Reaches Planned Enrollment Of 20 Patients For Interim Analysis In Istaroxime Phase 2 SEISMiC C Study In SCAI Stage C Cardiogenic Shock Patients

Parker Hannifin To Acquire Curtis Instruments For ~$1B In Cash; Curtis Expects Calendar Year 2025 Sales Of ~$320M

Vail Resorts, Inc. (NYSE:&nbsp;MTN) today announced it intends to commence a private offering to eligible purchasers, subject to market and other conditions, of $400 million in aggregate principal amount of senior notes due 2030 (the "Notes"). The Notes will be unsecured senior obligations of the Company and will be guaranteed by certain of the Company's domestic subsidiaries (other than certain excluded subsidiaries).
The Company intends to use the proceeds from the proposed offering to repay borrowings under its revolving credit facility incurred to fund the repurchase of $200 million of its outstanding shares of common stock completed in June 2025 and the repurchase or repayment of a portion of its outstanding 0.00% Convertible Senior Notes due 2026 at or prior to their maturity on January 1, 2026, and, in each case, to pay related fees and expenses. This press release does not constitute an offer to repurchase the Company's outstanding 0.00% Convertible Senior Notes due 2026.

Vail Resorts Intends To Commence Private Offering Of $400M In Aggregate Principal Amount Of Senior Notes Due 2030

Across the recent three months, 15 analysts have shared their insights on ARM Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ARM#NASDAQ">ARM</a>), expressing a variety of opinions spanning from bullish to bearish.
The table below offers a condensed view of their recent ratings, showcasing the changing sentiments over the past 30 days and comparing them to the preceding months.
<table>
<thead>
<tr>
<th></th>
<th align="right">Bullish</th>
<th align="right">Somewhat Bullish</th>
<th align="right">Indifferent</th>
<th align="right">Somewhat Bearish</th>
<th align="right">Bearish</th>
</tr>
</thead>
<tbody>
<tr>
<td>Total Ratings</td>
<td align="right">8</td>
<td align="right">7</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>Last 30D</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>1M Ago</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>2M Ago</td>
<td align="right">5</td>
<td align="right">5</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>3M Ago</td>
<td align="right">2</td>
<td align="right">2</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
</tbody>
</table>
Analysts have recently evaluated ARM Holdings and provided 12-month price targets. The average target is $152.2, accompanied by a high estimate of $187.00 and a low estimate of $115.00. Highlighting a 12.99% decrease, the current average has fallen from the previous average price target of $174.93. 
<img src="https://www.benzinga.com/files/images/story/2025/1751288463_0.png" alt="price target chart" />
<h2>Understanding Analyst Ratings: A Comprehensive Breakdown</h2>
The analysis of recent analyst actions sheds light on the perception of ARM Holdings by financial experts. The following summary presents key analysts, their recent evaluations, and adjustments to ratings and price targets.
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>John Difucci</td>
<td>Guggenheim</td>
<td>Raises</td>
<td>Buy</td>
<td>$187.00</td>
<td>$147.00</td>
</tr>
<tr>
<td>Ananda Baruah</td>
<td>Loop Capital</td>
<td>Lowers</td>
<td>Buy</td>
<td>$155.00</td>
<td>$195.00</td>
</tr>
<tr>
<td>Andrew Gardiner</td>
<td>Citigroup</td>
<td>Lowers</td>
<td>Buy</td>
<td>$170.00</td>
<td>$200.00</td>
</tr>
<tr>
<td>Vivek Arya</td>
<td>B of A Securities</td>
<td>Lowers</td>
<td>Buy</td>
<td>$135.00</td>
<td>$144.00</td>
</tr>
<tr>
<td>Srini Pajjuri</td>
<td>Raymond James</td>
<td>Lowers</td>
<td>Outperform</td>
<td>$140.00</td>
<td>$175.00</td>
</tr>
<tr>
<td>Blayne Curtis</td>
<td>Barclays</td>
<td>Lowers</td>
<td>Overweight</td>
<td>$115.00</td>
<td>$125.00</td>
</tr>
<tr>
<td>Harlan Sur</td>
<td>JP Morgan</td>
<td>Lowers</td>
<td>Overweight</td>
<td>$150.00</td>
<td>$175.00</td>
</tr>
<tr>
<td>John Vinh</td>
<td>Keybanc</td>
<td>Lowers</td>
<td>Overweight</td>
<td>$175.00</td>
<td>$195.00</td>
</tr>
<tr>
<td>John Difucci</td>
<td>Guggenheim</td>
<td>Lowers</td>
<td>Buy</td>
<td>$147.00</td>
<td>$180.00</td>
</tr>
<tr>
<td>Joe Quatrochi</td>
<td>Wells Fargo</td>
<td>Lowers</td>
<td>Overweight</td>
<td>$145.00</td>
<td>$150.00</td>
</tr>
<tr>
<td>Kevin Cassidy</td>
<td>Rosenblatt</td>
<td>Lowers</td>
<td>Buy</td>
<td>$180.00</td>
<td>$203.00</td>
</tr>
<tr>
<td>Timothy Arcuri</td>
<td>UBS</td>
<td>Lowers</td>
<td>Buy</td>
<td>$165.00</td>
<td>$215.00</td>
</tr>
<tr>
<td>Joe Quatrochi</td>
<td>Wells Fargo</td>
<td>Lowers</td>
<td>Overweight</td>
<td>$150.00</td>
<td>$185.00</td>
</tr>
<tr>
<td>Blayne Curtis</td>
<td>Barclays</td>
<td>Lowers</td>
<td>Overweight</td>
<td>$125.00</td>
<td>$155.00</td>
</tr>
<tr>
<td>Vivek Arya</td>
<td>B of A Securities</td>
<td>Lowers</td>
<td>Buy</td>
<td>$144.00</td>
<td>$180.00</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li>Action Taken: In response to dynamic market conditions and company performance, analysts update their recommendations. Whether they 'Maintain', 'Raise', or 'Lower' their stance, it signifies their reaction to recent developments related to ARM Holdings. This insight gives a snapshot of analysts' perspectives on the current state of the company.</li>
<li>Rating: Analyzing trends, analysts offer qualitative evaluations, ranging from 'Outperform' to 'Underperform'. These ratings convey expectations for the relative performance of ARM Holdings compared to the broader market.</li>
<li>Price Targets: Analysts set price targets as an estimate of a stock's future value. Comparing the current and prior price targets provides insight into how analysts' expectations have changed over time. This information can be valuable for investors seeking to understand consensus views on the stock's potential future performance.</li>
</ul>
Considering these analyst evaluations in conjunction with other financial indicators can offer a comprehensive understanding of ARM Holdings's market position. Stay informed and make well-informed decisions with our Ratings Table.
<a href="https://www.benzinga.com/quote/ARM/analyst-ratings?adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantage">Stay up to date on ARM Holdings analyst ratings.</a>
<h2>Unveiling the Story Behind ARM Holdings</h2>
Arm Holdings is the IP owner and developer of the ARM architecture, which is used in 99% of the world's smartphone CPU cores, and it also has high market share in other battery-powered devices like wearables, tablets, or sensors. Arm licenses its architecture for a fee, offering different types of licenses depending on the flexibility the customer needs. Customers like Apple or Qualcomm buy architectural licenses, which allow them to modify the architecture and add or delete instructions to tailor the chips to their specific needs. Other clients directly buy off-the-shelf designs from Arm. Both off-the-shelf and architectural customers pay a royalty fee per chip shipped.
<h3>Unraveling the Financial Story of ARM Holdings</h3>
Market Capitalization: With restricted market capitalization, the company is positioned below industry averages. This reflects a smaller scale relative to peers.
Revenue Growth: ARM Holdings displayed positive results in 3M. As of 31 March, 2025, the company achieved a solid revenue growth rate of approximately 33.73%. This indicates a notable increase in the company's top-line earnings. As compared to competitors, the company surpassed expectations with a growth rate higher than the average among peers in the Information Technology sector.
Net Margin: ARM Holdings's financial strength is reflected in its exceptional net margin, which exceeds industry averages. With a remarkable net margin of 16.92%, the company showcases strong profitability and effective cost management.
Return on Equity (ROE): ARM Holdings's ROE falls below industry averages, indicating challenges in efficiently using equity capital. With an ROE of 3.17%, the company may face hurdles in generating optimal returns for shareholders.
Return on Assets (ROA): ARM Holdings's ROA surpasses industry standards, highlighting the company's exceptional financial performance. With an impressive 2.41% ROA, the company effectively utilizes its assets for optimal returns.
Debt Management: With a below-average debt-to-equity ratio of 0.05, ARM Holdings adopts a prudent financial strategy, indicating a balanced approach to debt management.
<h2>Understanding the Relevance of Analyst Ratings</h2>
Within the domain of banking and financial systems, analysts specialize in reporting for specific stocks or defined sectors. Their work involves attending company conference calls and meetings, researching company financial statements, and communicating with insiders to publish "analyst ratings" for stocks. Analysts typically assess and rate each stock once per quarter.
Some analysts also offer predictions for helpful metrics such as earnings, revenue, and growth estimates to provide further guidance as to what to do with certain tickers. It is important to keep in mind that while stock and sector analysts are specialists, they are also human and can only forecast their beliefs to traders.
Breaking: Wall Street's Next Big Mover
Benzinga's #1 analyst just identified a stock poised for explosive growth. This under-the-radar company could surge 200%+ as major market shifts unfold. <a href="https://www.benzinga.com/premium/ideas/turning-point-trader-checkout-2/?t=Tu1tu3arja3be22tu36&amp;adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantag">Click here for urgent details</a>.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Comments

TaskUs

매도 수량

TaskUs (NASDAQ:TASK) 주식, 공매도 수량 보고

사람들이 또한 지켜본다

뉴스

파트너 / 기고자

벤징가 글로벌